Prognostic Value Analysis of Mutational and Clinicopathological Factors in Non-Small Cell Lung Cancer

• Chenguang Li ,

  Contributed equally to this work with: Chenguang Li, Ligang Hao

  Affiliations Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China, Tianjin Lung Cancer Center, Tianjin, China

  ⨯
• Ligang Hao ,

  Contributed equally to this work with: Chenguang Li, Ligang Hao

  Affiliations Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China, Tianjin Lung Cancer Center, Tianjin, China

  ⨯
• Yue Li,

  Affiliations Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China, Tianjin Lung Cancer Center, Tianjin, China

  ⨯
• Shengguang Wang,

  Affiliations Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China, Tianjin Lung Cancer Center, Tianjin, China

  ⨯
• Hui Chen,

  Affiliations Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China, Tianjin Lung Cancer Center, Tianjin, China

  ⨯
• Lianmin Zhang,

  Affiliations Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China, Tianjin Lung Cancer Center, Tianjin, China

  ⨯
• Bin Ke,

  Affiliations Key Laboratory of Cancer Prevention and Therapy, Tianjin, China, Department of Gastric Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

  ⨯
• Yuesong Yin,

  Affiliations Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China, Tianjin Lung Cancer Center, Tianjin, China

  ⨯
• Haijin Suo,

  Affiliations Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China, Tianjin Lung Cancer Center, Tianjin, China, Department of Surgery, Tianjin Beichen Hospital, Tianjin, China

  ⨯
• Bingsheng Sun,

  Affiliations Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China, Tianjin Lung Cancer Center, Tianjin, China

  ⨯
• Bin Zhang,

  Affiliations Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China, Tianjin Lung Cancer Center, Tianjin, China

  ⨯
• Changli Wang

  * E-mail: wangchangli@medmail.com.cn

  Affiliations Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China, Tianjin Lung Cancer Center, Tianjin, China

  ⨯